| Total population n = 1851 |
Anticoagulant use (n = 287) |
No anticoagulant use (n = 1564) |
P‐value | Standardized mean difference |
Anticoagulant use (n = 253) |
No anticoagulant use (n = 253) |
P‐value | Standardized mean difference |
|---|---|---|---|---|---|---|---|---|
| Age*, years mean (SD) | 76.75 (10.36) | 64.54 (14.75) | <0.001 | 0.957 | 76.47 (16.00) | 75.89 (10.10) | 0.523 | 0.012 |
| Time in pandemic* in days, mean (SD) | 45.69 (15.56) | 46.88 (16.37) | 0.253 | 0.075 | 45.55 (15.28) | 46.96 (16.21) | 0.419 | 0.071 |
| Women*, n (%) | 98 (34) | 615 (39) | 0.112 | 0.108 | 89 (35) | 91 (36) | 1.000 | 0.008 |
| Diabetes*, n (%) | 100 (35) | 382 (25) | <0.001 | 0.228 | 89 (35) | 100 (39) | 0.359 | 0.008 |
| Asthma*, n (%) | 21 (7) | 171 (11) | 0.077 | 0.128 | 20 (8) | 23 (9) | 0.750 | 0.045 |
| Obesity*, n (%) | 85 (32) | 439 (30) | 0.726 | 0.028 | 81 (32) | 87 (34) | 0.571 | 0.043 |
| Hypertension, n (%) | 168 (59) | 684 (44) | <0.001 | 0.296 | 152 (60) | 156 (62) | 0.785 | 0.032 |
| Temperature at admission in °C, mean (SD) | 37.68 (1.28) | 37.82 (1.16) | 0.062 | 0.116 | 37.70 (1.31) | 37.81 (1.24) | 0.308 | 0.091 |
| Oxygen saturation in %, mean (SD) | 93.2 (6.38) | 93.1 (5.85) | 0.737 | 0.021 | 93.3 (6.44) | 92.9 (5.85) | 0.453 | 0.067 |